Cornell University - Weill Cornell Graduate School of Medical Sciences: Prior Authorization Bans for Buprenorphine Alone May Not Improve Treatment Retention
March 07, 2026
March 07, 2026
NEW YORK, March 7 -- Cornell University - Weill Cornell Graduate School of Medical Sciences issued the following news:
* * *
Prior Authorization Bans for Buprenorphine Alone May Not Improve Treatment Retention
State laws that ban insurance prior authorization for buprenorphine--a leading medication for opioid use disorder--may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. Though . . .
* * *
Prior Authorization Bans for Buprenorphine Alone May Not Improve Treatment Retention
State laws that ban insurance prior authorization for buprenorphine--a leading medication for opioid use disorder--may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. Though . . .